Highlights Theraclion

Equities

ALTHE

FR0010120402

Real-time Euronext Paris Other stock markets 05:15:36 16/05/2024 pm IST			5-day change	1st Jan Change
0.498 ^EUR	+0.81%		-3.86%	+28.35%

27/03	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	27/03	CI
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	24/23/24	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	11/23/11	CI
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	28/23/28	CI
Theraclion: capital increase completed	23/23/23	CF
Global markets live: HSBC, Logitech, Uber, IBM, BP...	02/23/02
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Theraclion SA Announces US Food Drug Administration Approve Investigational Device Exemption Application to Initiate the Multi-Center Pivotal Study VEINRESET for the Treatment of Primary Insufficiency of Great Saphenous Veins with SONOVEIN	17/23/17	CI
Theraclion Announces Results of First US Trial	30/23/30	CI
University of Virginia Cancer Center to Use Theraclion's HD Technology	21/22/21	CI
Theraclion SA Announces Last Patient of First Sonovein(R) US Study Has Been Treated	17/22/17	CI
Theraclion New Echotherapy for Varicose Veins Partnership with Parisian Region Hospital Wound Center Announced	29/22/29	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2022	26/22/26	CI
Theraclion SA Announces the Launch of SONOVEIN® HD	16/22/16	CI
Theraclion Announces the Treatment of Varicose Veins Patients with Sonovein for the First Time in the United States	11/22/11	CI
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31	CI
Theraclion SA Announces First Patient Treatment in an Early-Stage Breast Cancer Study in Collaboration with the University of Virginia Cancer Center, USA	09/22/09	CI
Theraclion Unveils the Launch of SONOVEIN	31/22/31	CI
Theraclion?s First Varicose Veins Treatment in Hong-Kong Opens Perspectives in Asia	23/21/23	CI
FDA Approves the 1st Trial with Theraclion's Vein Therapy in the US	21/21/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Theraclion

Equities

ALTHE

FR0010120402

Highlights

Filters